NCT06142344View on ClinicalTrials.gov

Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients

NARecruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

October 19, 2023

Primary Completion Date

October 19, 2025

Study Completion Date

January 19, 2026

Conditions
Liver MetastasesBreast Cancer
Interventions
DEVICE

Quiremspheres™

The intervention comprises two steps. Initially, the patient will undergo mapping angiography and a Ho-166 scout dose. If deemed eligible, the patient will proceed to 166-Ho radioembolization.

Trial Locations (2)

3000

NOT_YET_RECRUITING

University Hospital Leuven, Leuven

1066 CX

RECRUITING

Netherlands Cancer Institute, Amsterdam

All Listed Sponsors
collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

lead

The Netherlands Cancer Institute

OTHER